Skip to Content
Merck
CN
  • Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.

Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.

Science (New York, N.Y.) (1995-11-03)
S M Russell, N Tayebi, H Nakajima, M C Riedy, J L Roberts, M J Aman, T S Migone, M Noguchi, M L Markert, R H Buckley, J J O'Shea, W J Leonard
ABSTRACT

Males with X-linked severe combined immunodeficiency (XSCID) have defects in the common cytokine receptor gamma chain (gamma c) gene that encodes a shared, essential component of the receptors of interleukin-2 (IL-2), IL-4, IL-7, IL-9, and IL-15. The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c, so it was hypothesized that defects in Jak3 might cause an XSCID-like phenotype. A girl with immunological features indistinguishable from those of XSCID was therefore selected for analysis. An Epstein-Barr virus (EBV)-transformed cell line derived from her lymphocytes had normal gamma c expression but lacked Jak3 protein and had greatly diminished Jak3 messenger RNA. Sequencing revealed a different mutation on each allele: a single nucleotide insertion resulting in a frame shift and premature termination in the Jak3 JH4 domain and a nonsense mutation in the Jak3 JH2 domain. The lack of Jak3 expression correlated with impaired B cell signaling, as demonstrated by the inability of IL-4 to activate Stat6 in the EBV-transformed cell line from the patient. These observations indicate that the functions of gamma c are dependent on Jak3 and that Jak3 is essential for lymphoid development and signaling.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
JAK3 (781-end), active, GST tagged human, PRECISIO® Kinase, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution